House Bill 6231
116th Congress(2019-2020)
Ensuring Access to COVID-19 Preventive Care Act of 2020
Introduced
Introduced in House on Mar 12, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
6231
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No House votes have been held for this bill.
Summary
Ensuring Access to COVID-19 Preventive Care Act of 2020
This bill requires private health insurance plans to cover diagnostic tests for COVID-19 (i.e., coronavirus disease 2019) without imposing cost sharing. The requirement applies only: (1) to tests designated by the Department of Health and Human Services, and (2) during the public health emergency declared on January 31, 2020.
The bill also shortens to 15 business days the time frame under which the Advisory Committee on Immunization Practices must issue a recommendation after a vaccine intended to treat or prevent COVID-19 is licensed by the Food and Drug Administration.
March 12, 2020
03/12/2020
Referred to the House Committee on Energy and Commerce.
03/12/2020
Introduced in House
Public Record
Record Updated
Feb 8, 2022 11:14:42 PM